InvestorsHub Logo
Followers 36
Posts 1266
Boards Moderated 0
Alias Born 05/17/2011

Re: BioChica post# 1868

Wednesday, 05/18/2011 4:11:35 PM

Wednesday, May 18, 2011 4:11:35 PM

Post# of 8439
What do you mean not likely until then??? What about Meda milestone payments to the tune of millions -- could happen anytime! Then, continuing royalties after that to the tune of millions per years. Effirma is a blockbuster drug, action like none other on the market. All the others on the market are toxic and do little to help fibromyalgia.

Labeling news re: reaZin in a matter of weeks, even days! That piggie is going to market! LOL

Trimesta is over 90% enrolled. PPS should get a bump when it's fully enrolled. People like good written news. And according to the CC yesterday, Trimesta can work on men as well as women, therby increasing the market!

Oh and the lab is profitable for the first time and growing by over 400%, not too shabby.

AEN is my FAVORITE long-term play, with some short term action to boot.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News